Psychedelic Microdosing and Drug Interactions
An episode of the Neural Pharm Podcast podcast, hosted by Dr. Colby Burns, PharmD and Dr. Christopher Toney, PharmD, titled "Psychedelic Microdosing and Drug Interactions " was published on September 5, 2023 and runs 36 minutes.
September 5, 2023 ·36m · Neural Pharm Podcast
Episode Description
References:
Cheung T. COMPASS Announces Positive Outcome of 25 mg COMP360 Psilocybin Therapy as Adjunct to SSRI Anti-depressant in Open-Label, Treatment-Resistant Depression Study. COMPASS Health. 13 Dec 2021 [press release].
Grinspoon P. The Popularity of Microdosing of Psychedelics: What Does the Science Say? Harvard Health. 19 Sept 2022.
Gukasyan N, et al. Attenuation of Psilocybin Mushroom Effects During and After SSRI/SNRI Anti-depressant Use. Sage Journals. 2023 Jul; 37(7): 707-716
Malcolm B and Thomas K. Serotonin Toxicity of Serotonergic Psychedelics. Psychopharmacology. 2022;239: 1881-1891
Perez E, et al. The Psilocybin-Blunting Effects of SSRIs and Anti-depressants. Psychedelic Passage. 3 June 2022.
Raison C, et al. Single Dose Psilocybin for Major Depressive Disorder. JAMA. 2023; 330(9): 843-853
Drug Interaction tables for reference:
Microdosing mom article mentioned in podcast: https://psychedelicspotlight.com/indiana-nurse-faces-ten-years-in-prison-for-microdosing-psilocybin-mushrooms/
Get full access to Neural Pharm at neuralpharm.substack.com/subscribe
Similar Episodes
Apr 10, 2026 ·38m
Apr 10, 2026 ·33m
Apr 7, 2026 ·9m
Apr 4, 2026 ·36m
Mar 31, 2026 ·8m